A056

CG MedTechLtd Stock Price

Symbol: KOSDAQ:A056090Market Cap: ₩105.3bCategory: Healthcare

A056090 Share Price Performance

₩1,018.00
-324.00 (-24.14%)
₩1,018.00
-324.00 (-24.14%)
Price ₩1,018.00

A056090 Community Narratives

There are no narratives available yet.

A056090 Community Fair Values

    Recent A056090 News & Updates

    No updates

    CG MedTech Co.,Ltd. Key Details

    ₩38.0b

    Revenue

    ₩21.2b

    Cost of Revenue

    ₩16.8b

    Gross Profit

    ₩15.3b

    Other Expenses

    ₩1.5b

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    14.63
    Gross Margin
    44.29%
    Net Profit Margin
    3.97%
    Debt/Equity Ratio
    3.1%

    CG MedTech Co.,Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About A056090

    Founded
    1993
    Employees
    105
    CEO
    Ju mi Chung
    WebsiteView website
    www.cgmedt.com

    CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as UniSpace Stand-Alone C Cage, a standalone anterior cervical interbody fusion device. It also provides Benefix interspinous fixation systems for the immobilization and stabilization of the spinous processes; ANAX 5.5 posterior spinal fixation system; ANAX 5.5 MIS System, ANAX 5.5 CT Spinal System, U&I Retractor; Perfix spinal system, a posterior and non-cervical pedicle fixation system, that includes Iliac screw, MIS system, level extension device; Spinal Hook system that provides distraction, compression, axial rotation, and anterior-posterior correction of deformities from thoracic spine to sacral spine; and Neo IC Cylindrical, Velofix TLIF cage, and Neo IC Square cage, as well as INNOVERSE spinal system. In addition, the company provides Polarfix facet screw fixation system, SECULOK interference screw and shoulder anchor; PRO-DENSE Bone graft substitute, MIIG X3 injectable graft, and OSTEOSET products, as well as LIFEGRAFT. Further, it offers Dyna Locking Trochanteric Nail; Dyna Locking Ankle Nail; Dyna Locking IM Nail; Dyna Locking Cannulated Screw; EXPEDIO balloon catheter, an interventional medical device; and L'DISQ for radicular and discogenic pain, as well as velofuse gel and putty, an injectable demineralized bone fiber. The company was formerly known as Innosys Co., Ltd. and changed its name to CG MedTech Co.,Ltd. in November 2024. The company was founded in 1993 and is headquartered in Uijeongbu-si, South Korea.

    South Korean Market Performance

    • 7 Days: -2.0%
    • 3 Months: 20.9%
    • 1 Year: 26.1%
    • Year to Date: 28.6%
    Over the last 7 days, the market has dropped 2.0%, driven by losses in the Materials and Information Technology sectors of 7.0% and 1.3%, respectively. As for the longer term, the market has actually risen by 26% in the last year. As for the next few years, earnings are expected to grow by 22% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading